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Abstract 
The purpose of this study is to use Health Technology Assessment (HTA) through the Six Sigma 
(SS) and DMAIC (Define, Measure, Analyse, Improve, Control) problem-solving strategies for 
comparing cemented and uncemented prostheses in terms of the costs incurred for Total hip 
arthroplasty (THA) and the length of hospital stay (LOS). Multinomial logistic regression 
analysis for modelling the data was also performed. Quantitative parameters extracted from gait 
analysis, electromyography and computed tomography images were used to compare the 
approaches, but the analysis did not show statistical significance. The variables regarding costs 
were studied with the Mann-Whitney and Kruskal-Wallis tests. No statistically significant 
difference between cemented and uncemented prosthesis for the total cost of LOS was found, 
but the cost of the surgeon had an influence on the overall expenses, affecting the cemented 
prosthetic approach. The material costs of surgery for the uncemented prosthesis and the cost of 
theatre of surgery for the cemented prosthesis were the most influential. Multinomial logistic 
regression identified the Vastus Lateralis variable as statistically significant. The overall 
accuracy of the model is 93.0%. The use of SS and DMAIC cycle as tools of HTA proved that 
the cemented and uncemented approaches for THA have similar costs and LOSy. 
Key Words: health technology assessment; six sigma; cost analysis; multinomial logistic 
regression; total hip arthroplasty. 
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 Total hip arthroplasty (THA) is one of the most 
frequent and successful surgical procedures that aims to 
make patients' lives better through prosthetic 
replacement of diseased acetabular and femoral heads.1 
In recent years, THA is considered a safe procedure and 
postoperative morbidity and mortality has decreased.2  
Changes in living conditions have led to an increase in 
age of the elderly population and orthopaedic surgeons 
are increasingly finding themselves treating a greater 
number of elderly patients who need to undergo THA. 
For THA, bone quality, assessed from conventional 
radiograms, is one of the variables, including the 
patient’s age, sex, and lifestyle, together with the 
efficiency and assessments of the surgeon, which can 
influence the choice of the type of implant and the most 
appropriate method of fixation for the surgery.3-6 
There are different approaches to THA, but those 
analysed in this study include the use of acrylic bone 
cement (cemented prosthesis) and a pressure fitting 
against the bone (uncemented prosthesis). However, the 
debate concerning the choice of cemented or uncemented 
fixation occurs frequently. The advantages of the 
uncemented procedure include a lower risk of 
cardiovascular and thromboembolic complications 
linked to the cement, the possibility of biological 
fixation, the reduction of stress of the proximal femur and 
extended implant survival potential and easier late 
revision. Bone fusion is the key to supporting the use of 
uncemented components.7,8 The upper bone-implant 
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interface, created from components coated with 
hydroxyapatite, produces a constantly remodelling seal 
between living bone and inert metal, providing excellent 
fixation.9 In contrast, the choice of the cemented 
approach provides an immediate post-operative 
advantage in terms of a better integration between bone, 
cement and the prosthesis, which allows an early relief of 
pain.10 The success of the implant after THA is the most 
frequent study object and even if studies have shown the 
success of the procedure, failures can always happen. In 
order to prevent this, doctors recommend routine follow-
up visits. Obviously, these reviews are expensive for both 
the patient and the health system given the growing 
number of THA procedures performed. Thus, it would be 
useful to identify an economic model for the management 
of patients after surgery.11,12 Therefore, orthopaedic 
surgeons increasingly need sound economic evidence to 
understand the full value of the operation, to make 
decisions about available procedures and to justify their 
practice beyond the traditional clinical preference. 
Literature shows that managing resources is an important 
test by trying to evaluate the cost of replenishing the 
implant compared to the cost of the entire procedure and 
patient's path. By comparing the two cemented and 
uncemented approaches uncemented implants seem more 
expensive.13  From studies that have taken into 
consideration the cost of the implant, the length of 
hospital stay(LOS), the probability of reoperations, the 
duration in the operating room, it emerges that the 
cementless procedures can be slightly faster but there are 
tests that indicate that cemented arthroplasties are 
cheaper in the long run.14 Various approaches and 
innovative methodologies have been introduced to 
reduce waste in healthcare, in particular by acting on the 
waiting times in the hospital.15,16 Advanced analytical 
techniques have also been introduced to healthcare to 
help physicians and clinicians with the diagnosis,17-19 and 
investigation of disease prognosis.20-22 The result is a 
difference between what is technologically possible and 
what can be sustained economically.23 Therefore, the 
purpose of this work will be to use the Health Technology 
Assessment (HTA) through the Six Sigma (SS) 
methodology for the comparison between cemented and 
uncemented prostheses as regards the costs [with 
euro/Iceland Krona (ISK) currency of 136,8 per day 
29/01/2020] and the LOS by using the SS methodology 
and finally a multinomial logistic regression analysis for 
modelling the data. This article can serve as a guide on 
how to apply the SS approach to improve the quality of 
healthcare. Obviously not to provide answers to precise 
questions, but to understand the various factors in 
determining costs of THA. 
Materials and Methods 
Literature Review 
Over the past decades, several countries have faced the 
challenge of controlling rising health costs and spending. 
Although the presentation of new technologies in 
healthcare has been understood as a significant cost 
factor, at the same time the new technologies have been 
producing important qualitative improvements. One of 
the widespread mechanisms is the HTA evaluation.24 
HTA is a multidisciplinary process that summarizes 
information on clinical, economic, social and ethical 
issues related to the use of health technology, in a 
systematic, transparent, impartial and solid way. Its goal 
is to contribute to the identification of safe, effective, 
patient centred health policies aimed at achieving the best 
value. The HTA process is based on scientific evidence 
from studies; indeed, this approach was applied to 
examine the problem of surgical infections in patients 
with oral cavity cancer by comparing two drugs in terms 
of shorter duration of LOS,25 and maximizing health 
gains through efficient use of resources in Saudi Arabia.24  
Therefore, the quality of healthcare is a matter of great 
concern and finding ways to improve quality and reduce 
costs is one of the most important issues. To tackle them, 
a management tool that has emerged in healthcare is the 
SS methodology.26 SS and its philosophy have found 
development in many manufacturing industries and are 
currently widely used in healthcare; the method of 
improvement and resolution of problems is described by 
the DMAIC (Define, Measure, Analyse, Improve, 
Control) approach which develops in five phases. The 
DMAIC roadmap is applied in healthcare in various 
fields such as first aid,17 orthopaedics,27,28 and reduction 
of hospital infections,29 The SS methodology is often 
associated with Lean Thinking with the aim of increasing 
positive healthcare outcomes, patient satisfaction by 
eliminating waste, and reducing costs.24,30-32 Application 
of these methodologies has led to great successes in 
healthcare, in fact many studies show improvements in 
processes such as increased productivity,33 increased 
quality by eliminating waste in hospital operating costs,34 
and improved efficiency in the process of hip 
replacement surgery in Finland.35 The methodology was 
applied for the introduction of a diagnostic-therapeutic-
assistance path to reduce LOS and costs in the 
management of elderly patients with femur fracture,36 
and to analyse a clinical path through fast track surgery 
to improve the quality and reduce the costs associated 
with prosthetic hip and knee replacement surgery.37,38 
The SS methodology was also combined with agile 
manufacturing to manage waiting lists and absenteeism 
of patients in order to avoid wasting time and 
resources.39,40 This work focused on the application of the 
SS methodology for reducing hospital costs related to 
THA by comparing the cemented and uncemented 
approaches. 
The Clinical Study 
The study was conducted at the Landspítali University 
Hospital in Reykjavik, Iceland. This is the leading 
hospital in Iceland, the largest workplace for employees 
in healthcare and has a capacity of 700 beds, performing 
about 300-400 surgical procedures a year. The data were 
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extracted from a database at the hospital. The initial study 
included 70 patients who underwent THA for the first 
time to try to improve their quality of life. 34 received a 
cemented hip prosthesis and 36 received an uncemented 
prosthesis. The prostheses used were manufactured by 
Zimmer. Patient pre- and post-operative assessment was 
approved by the Icelandic Bioethics committee 
(Application number: 13-127-S1—Study type and level 
of evidence: ‘‘Level 2 prospective cohort study’’). All 
patients underwent a Computed Tomography (CT) scan 
(64 CT Philips Brilliance) before and immediately after 
the operation and 52 weeks after surgery and also a 
biomechanical analysis at the Landspítali rehabilitation 
clinic 1–2 days before and 1 year after surgery. 
Moreover, the gait parameters were obtained together 
with electromyographic (EMG) signals, used as a tool to 
define muscle activation in experimental studies on 
human walking.37 They were recorded on the patients' 
quadriceps [Rectus femoris (RF), Vastus lateralis (VL) 
and Vastus medialis (VM)] with a frequency of 1600Hz 
using the Kine Pro system.1 Furthermore, the CT data 
were optimized for post-processing segmentation for the 
creation of 3D models of bone and muscle to simulate 
and calculate bone mineral density (BMD),38 useful for 
information on the structural integrity of the bone as the 
loss of BMD could make the bone weaker and more 
susceptible to fractures, negatively affecting the 
mechanical stability of an implanted prosthesis.3 For each 
patient the following variables were collected: gender, 
age, gait parameters, BMD, EMG analysis, allergies, 
body mass index (BMI), comorbidities and costs 
associated to each patient. The costs for both approaches 
(cemented and uncemented) will be analysed.  
They are divided into the following categories: 
• Cost of hospital stay: 
o Surgeon cost 
o Other costs (i.e. costs related to hospital stay) 
o Administration costs. 
• Surgical cost: 
o Material cost of surgery 
o Surgical theatre cost of surgery 
o Anaesthesia 
o Awakening from anaesthesia 
Development of the methodology (The define phase) 
In this phase, the purpose of the cycle is to define a 
multidisciplinary work team and divide the tasks of 
analysis. The team is made up of biomedical engineers, a 
surgeon and a biologist with an experience in health 
management. The team was responsible for collecting 
and analysing the data of hospital costs, breaking down 
hospital and surgical costs during the stay in the hospital 
according to some variables. The champion and the 
leader supervised and coordinated the study and gave 
conceptual help in interpreting the data. In SS projects, 
the champion is the person in a company translating the 
mission, vision, and values into a SS deployment strategy 
while the leader coordinates a SS project under the 
direction of the champion. 
Initially, a project diagram was created to define the 
problem to solve: 
● Project title: HTA through SS methodology to assess 
cemented and uncemented protheses in THA. 
● Question: comparison of cemented and uncemented 
prosthesis. 
● Critical to quality: Costs [€] and LOS [days]. 
● Target: Finding the prosthesis allowing lower costs 
and shorter LOS. 
● In scope:  
○ Reykjavík University, Institute for Biomedical and 
Neural Engineering and Landspítali Hospital, 
Orthopaedic Clinic, Reykjavík, Iceland.  
○ THA. 
● Out of scope: All the other structures and 
interventions. 
● Financial: No funding was provided to reach the 
target. 
● Business need: Identifying the cost that most affects 
the prosthesis. 
Finally, a SIPOC (Suppliers-Inputs-Process-Outputs-
Customers) scheme was a good tool to clarify the 
following main process characteristics:  
• Supplier: 
o Reykjavík University, Institute for Biomedical and 
Neural Engineering Iceland; 
o Landspítali Hospital, Orthopaedic Clinic, Reykjavík, 
Iceland;  
o Clinical staff. 
• Input: 
o Needs of patients; 
o THA;  
o Orthopaedic surgery. 
• Process: 
o Arrival at the hospital; 
o Clinical trials: gait analysis, BMD measurements, x-
ray muscles absorption, EMG analysis; 
o Recovery;  
o Uncemented or cemented plant choice; 
o Surgery;  
o Postoperative activities; 
o Discharge;  
o Check after a year. 
• Output: 
o Better recovery; 
o Improved outcome for patients; 
o Lower number of complications;  
o Reduction of hospital costs during stay. 
• Customers: 
o Patients; 
o Landspítali Hospital, Orthopaedic Clinic, Reykjavík, 
Iceland. 
Dataset description (The measure phase) 
Physiological and biometric measures were considered to 
compare the LOS of the two different surgical 
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approaches in the field of orthopaedic surgery. The 
following variables were collected for each patient: 
gender, age, walking parameters, BMD, EMG analysis, 
allergies, BMI, comorbidities. In particular, the gait 
parameters include step length, stride length, base 
support, single support, double support, swing, stance, 
toe in/out, velocity. The BMD was measured for: 
proximal, the part above the tip of the femoral stem, and 
distal, the part under the tip of the femoral stem. Finally, 
the parameters recorded on the quadriceps of the patients 
are the activation times of the VM, VL and RF. These 
variables were studied through a univariate statistical 
analysis. In particular, from the Shapiro-Wilk test the 
data emerged as not normally distributed. Therefore, the 
Mann-Whitney non-parametric test for independent 
samples was applied. Considering the costs for the 
cemented and uncemented approaches, described in the 
collection of data, the dataset is composed of patients 
who underwent THA for the first time and included all 
patients with a complete clinical history. After 
identifying the purpose of the study, the dataset and 
methodology, the costs were analysed. Initially, the 
Shapiro-Wilk test was applied (significance level α = 
0.05), necessary for the application of statistical tests. 
The total costs of hospital stay compared to surgical costs 
are those that have the greatest impact on both cemented 
and uncemented prostheses. 
Statistical analysis (The analysis phase) 
Figure 1 shows the surgical path of the patients, from 
arrival in hospital to discharge. Once in the hospital, the 
patients are subjected to various tests to determine the 
above-mentioned parameters. Then, they underwent 
 
Fig 1. Surgical path of the patients 
Table 1. Univariate analysis conducted through Kruskal Wallis to investigate variables influencing costs 
Category Breakdown of categories Cemented Uncemented 
 Mean ± Dev. Std. p-value Mean ± Dev. Std. p-value 
Total cost of 
hospital stay 
Surgeon cost 3884,33±961,47 <0,001 4366,88±1935,18 <0,001 
Other cost 2253,61±1058,39 1981,24±771,25 
Administration cost 360,43±141,90 326,28±120,60 
Surgical cost Material cost of surgery 1587,66±701,29 <0,001 2354,95±1615,60 <0,001 
Surgical theatre cost of 
surgery 
1299,12±537,55 1059,82±442,96 
Anaesthesia 782,85±248,90 741,81±307,87 
Awakening from anaesthesia 214,69±98,26 210,30±72,90 
 
Health technology assessment through Six Sigma Methodology 
Eur J Transl Myol 31 (1): 9651, 2021 doi: 10.4081/ejtm.2021.9651 
- 5 - 
 
surgery. After surgery, the patient undergoes post-
operation measurements and is evaluated for any 
potential post-surgical complication. Finally, when the 
patients are recovered sufficiently, they can be 
discharged and 6 weeks later they will return to the 
hospital for a check-up. In order to statistically evaluate 
the costs for the group of patients based on the collected 
variables, Kruskal-Wallis tests were performed on non-
dichotomous categories since the Shapiro-Wilk test 
showed a non-normal distribution of data. In this 
analysis, an alpha value of 0.05 is used as the cut off 
value for significance. 
Finally, Table 1 shows the results of the analyses 
indicating that both categories for the cemented and 
uncemented approaches statistically influence the costs 
(p-values<0.001). 
Comparing the prosthesis (The “Improve”) 
The hip is made up of a sphere and an orbit formed by the 
femur and a section of the pelvis, called the acetabulum. 
In a normal hip, the cartilage separates the sphere and the 
handle, thus allowing the ball to slide easily into the 
handle to cushion the joint. The hip can wear out at 
various points during life, so THA aims to improve 
patients' quality of life by providing a joint that functions 
as normally as possible, is resistant to dislocation, while 
trying to save as much bone as possible. There are several 
approaches to choose the type of implant in THA, but the 
one used in this study involves the use of acrylic bone 
cement (cemented prosthesis) and a pressure fitting 
against the bone (uncemented prosthesis). The selection 
of the type of implant and the most appropriate method 
of fixation depend on the preferences of the surgeon (age, 
effectiveness and bone quality).41,42 The prosthesis with 
cemented fixation, allows almost immediate ambulation, 
thus allowing fast rehabilitation. This solution is taken 
into consideration by patients over the age of 60 or those 
who have poor bone quality or severe forms of arthritis, 
although it is not very suitable for overweight or 
particularly active patients, as cement break-down could 
Table 2. Statistical analysis of LOS related to each variable and category 









Gender Males 5,20±1,79 4,29±0,61 0,391 
Females 4,75±0,93 4,80±0,63 0,856 
Age Age<68 4,73±1,01 4,46±0,52 0,494 
Age>69 5,00±1,33 4,55±0,82 0,223 
BMI BMI < 30 5,15±1,07 4,54±0,66 0,091 
BMI ≥ 30 4,37±1,19 4,45±0,69 1,000 
Allergies No 4,83±1,40 4,55±0,61 0,307 





Step Length  I 4,58±1,24 4,54±0,78 0,769 
II 5,22±0,97 4,45±0,52 0,080 
Stride Length  I 4,73±1,19 4,64±0,67 0,606 
II 5,00±1,15 4,38±0,65 0,166 
Base Support I 4,90±1,10 4,50±0,65 0,321 
II 4,82±1,25 4,50±0,71 0,426 
Single Support  I 4,67±1,32 4,50±0,71 0,720 
II 5,00±1,04 4,50±0,65 0,160 
Double Support I 4,77±0,83 4,53±0,64 0,363 
II 5,00±1,60 4,44±0,73 0,321 
Swing I 5,27±1,00 4,33±0,71 0,056 
II 4,40±1,17 4,60±0,63 1,000 
Stance  I 4,40±1,17 4,60±0,63 1,000 
II 5,27±1,00 4,33±0,71 0,056 
Toe In/Out I 4,73±1,14 4,42±0,52 0,379 
II 5,00±0,81 4,58±0,79 0,381 
Velocity 
 [m/s] 
I 5,33±0,58 4,60±0,52 0,161 
II 4,78±1,21 4,43±0,76 0,283 
 
CT  
Proximal I 4,69±0,95 4,63±0,92 0,750 
II 5,13±1,46 4,44±0,51 0,291 
Distal I 4,69±0,95 4,58±0,79 0,538 
II 5,13±1,46 4,42±0,52 0,305 
 
EMG 
RF I 4,82±1,25 4,25±0,62 0,104 
II 4,90±1,10 4,75±0,62 0,771 
VL I 4,82±1,25 4,50±0,80 0,347 
II 4,90±1,10 4,50±0,52 0,346 
VM I 4,56±1,13 4,44±0,73 0,605 
II 5,08±1,16 4,53±0,64 0,167 
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occur.43 The prosthesis with uncemented fixation, on the 
other hand, adheres directly to the bone without the use 
of cement thanks to the conformation of the surface of 
the prosthesis itself, which is able to facilitate the 
neoformation of bone tissue around the point of contact. 
The uncemented stems have different shapes (wedged, 
tapered, modular and anatomical) to guarantee the initial 
stability and bone contact. Since the stabilization 
between the bone and the prosthesis takes place over a 
longer period, it is necessary to walk with crutches for 6-
12 months after surgery. This type of intervention is 
recommended for younger, more active patients with 
better bone quality.41 
Control 
After carrying out the normality test of Shapiro-Wilk  
(with a level of uncertainty or an alpha equal to 0,05) 
which showed the data to not be normally distributed, 
some statistical tests with an alpha of 0,05 were applied 
to the subgroups in order to highlight statistically 
significant differences. The Mann-Whitney test was 
applied to compare costs and LOS between the two 
groups of patients. 
Multinomial logistic regression 
Multinomial logistic regression aims to study and 
quantify the relationships between one or more 
independent quantitative variables and a dichotomous 
dependent variable. In this study this model used the type 
of cemented and uncemented prosthesis as a dependent 
variable and all the other quantitative parameters as 
independent variables. 
The variables can be defined by the following equation 
(1): 
   𝑦𝑦 = 𝛽𝛽0 + 𝛽𝛽1𝑥𝑥1 + 𝛽𝛽2𝑥𝑥2 + 𝛽𝛽3𝑥𝑥3 + ⋯+ 𝛽𝛽𝑁𝑁𝑥𝑥𝑁𝑁   (1) 
where y is the value of the expected type of prosthesis, β0 
is the intercept value, xi are independent variables and βi 
estimated regression coefficients of the respective 
variables. 
Before building the model, it was necessary to make the 
following assumptions: 
1. Independent variables affected by multicollinearity 
must be removed. This is verified with a Pearson’s 
Bivariate Correlation test, correlations greater than 
0.8 are influential. 
2. Cook's Distance is used in regression analysis to find 
influential outliers in a set of predictive variables. It 
is a way of identifying points that negatively affect 
the regression model. This distance measures how 
much the residuals of all cases would change if a 
particular case were excluded from the calculation of 
the regression coefficients. A high coefficient 
indicates that, excluding the case from the analysis, 
the coefficients would have changed substantially. 
The centre leverage value indicates the data points 
that have the potential to shift a linear regression line.  
Multinomial logistic regression and model diagnostics 
were performed with IBM SPSS. 
Results 
Comparing cemented and ubcemented prostyesis in 
terms of LOS 
The average of the LOS for cemented and uncemented 
prosthesis is shown in Table 2. The data did not show 
statistical significance based on the categories analysed. 
The reference cut-off considered for each variable 
corresponds to the arithmetic mean of the collected 
Table 3. Statistical analysis of L of costs (in €) related to each category 









Total cost of 
hospital stay 
Overall 6751,38±1536,81  6879,59±2236,70 0,755 
Surgeon cost 253,01±104,19 205,18±97,69 0,010 
Other cost 2253,61±1058,39 1981,24±771,25 0,152 







Overall 3884,33±961,47 4366,88±1935,18 0,344 
Material cost of surgery 1587,66±701,29 2354,95±1615,60 0,013 
Surgical theatre cost 1299,12±537,55 1059,82±442,96 0,006 
Anaesthesia 782,85±248,90 741,81±307,87 0,332 
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values. However, the physiological and biometric 
measurements that appear to influence LOS are the 
percentage of gait cycle between last contact of the 
current footfall to the first contact of the next footfall 
(Swing) with a p-value of 0.056 and the percentage of 
gait cycle between two consecutive heel contacts and toe 
events on the same foot (Stance) with a p-value of 0.056.  
Cost analysis 
Each category, both the total costs of hospital stay and 
the surgical costs, was analysed with a non-parametric 
statistical test, the Mann-Whitney test, because the 
Shapiro-Wilk test for the normality of the data showed a 
p value lower than 0.01, meaning a non-normal 
distribution of data. From the tests reported in Table 3, it 
emerges that in the total cost of hospital stay category, 
there is not a statistically significant difference between 
cemented and uncemented in terms of cost but what most 
influences them is the surgeon cost (p-value = 0.010); in 
particular, the cemented prosthesis approach is affected 
more than the uncemented. For the surgical cost category 
there is no statistically significant difference between the 
two surgical approaches, but the material costs of surgery 
are the most influential ones (p-value = 0.013) for the 
uncemented prosthesis and the surgical theatre cost of 
surgery (p-value = 0.006) for the cemented prosthesis. 
Modelling 
The multinomial logistic regression attempted to 
distinguish between the cemented and uncemented 
prosthesis, the results are shown in Table 4. Two outliers 
were eliminated from the model. The four odds ratios of 
the variables included in the model are: age, RF, VL and 
BMI. The variables that gave significance show that the 
model reflects the parameters considered by the surgeon 
in the choice of the prosthesis to be implanted. The VL 
variable turns out to be almost statistically significant and 
therefore the muscular component could also be taken 
into consideration in the choice of the surgeon. The 
overall accuracy of the model is 93.0 %, the ability to 
detect cemented group is 90.0 % while the capacity to 
detect the uncemented group is 95.7 %. The Hosmer-
Lemeshow goodness of fit test proved the good overall 
quality of the model: p-value = 0.979 
Discussion 
The decision-making process relating to the type of 
prosthesis has been much discussed in the literature,41,44-
47 but different opinions on the subject remain.. The past 
objectives were to find differences between 
biomechanical parameters extracted from patients 
undergoing cemented and uncemented prosthesis THA.1 
The aim of this article was to use the HTA through the 
SS methodology for the comparison between cemented 
and uncemented prostheses, to investigate the economic 
differences between two groups receiving different types 
of prosthesis and finally a multinomial logistic regression 
analysis to model the data. The study shows how the SS 
methodology through the DMAIC cycle turns out to be a 
well-structured problem-solving strategy to address 
economic issues as well, as already demonstrated by 
other studies.31,32 In this case, it was used to compare the 
costs of hip replacement with the cemented and 
uncemented surgical approaches that patients underwent 
for the first time.  
The results obtained from the comparison between the 
two prostheses do not show statistical significance based 
on the categories analysed. However, the physiological 
and biometric measurements that appear to influence 
LOS are the percentage of the gait cycle between the last 
contact of the current gait and the first contact of the next 
step (Swing) and the percentage of the gait cycle between 
two consecutive heel contacts, and toe events on the same 
foot (Stance). A factor that could influence space-time 
parameters and gait kinematics is pain in walking ability 
after THA and therefore this could lengthen the LOS in 
hospital.48 
As for the results obtained under the guidance of the 
DMAIC through statistical tests and graphic 
representations, they show how in the total cost of the 
hospitalization category there is no statistically 
significant difference between cemented and 
uncemented, but what most influences the overall costs 
is the cost of the surgeon and in particular it has a greater 
influence on the cemented prosthetic approach. 
Table 4. Multinomial logistic regression results to distinguish cemented and uncemented prosthesis. 
Variables Odds Ratio (95% CI) p-value 
Age 0.582 (0.386 – 0.879) 0.010 
RF 0.789 (0.482 – 1.293) 0.347 
VL 1.956 (0.954 – 4.009) 0.067 
BMI 1.571 0.952 – 2.5692 0.077 
Odds ratio (95% confidence interval) and p-value for each variable considered in the model. 
*significance at 0.05, **significance at 0.01 
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Similarly, for the surgical costs category there is no 
statistically significant difference between the two 
surgical approaches, but the material cost of surgery for 
an uncemented prosthesis and the cost of theatre surgery 
for a cemented prosthesis are the most influential. 
Finally, the modelling of the data shows how the 
parameters are considered in the choice of prosthesis; 
other researchers have tried recently to model through 
machine learning analysis the choice of the surgeon in the 
type of prosthesis and demonstrated the importance of the 
EMG in this choice,49 specifically ML techniques were 
applied on quantitative biomechanical and bone quality 
data extracted from CT, EMG and gait analysis, aiming 
to help clinicians by using patient-specific biomarkers 
from diagnostic exams in the prosthetic decision-making 
process. The skeletal muscle parameters such as the start 
and stop of muscle contraction from EMG signals was 
particularly important for identifying the best prosthesis 
for patients. The novelty of this document is the use of 
the SS methodology with the DMAIC cycle to manage a 
health problem related to the costs incurred by the 
orthopaedic department. Obviously, SS cannot replace 
health technology assessment appropriately, but it could 
be a valuable analytical tool. A limitation in this study 
could be the exclusive use of the Zimmer prosthesis that 
was implemented in all patients; thus, it is not known 
whether a change in the prosthesis would affect the other 
costs. Moreover, all patients were Icelandic, and the 
National Health System may have had an influence on 
the results, but these factors may also be seen to 
strengthen the results as they are without any external 
corruption due to the implanted biomedical technology. 
Practical inplications 
Healthcare cost in hospitals is a very important topic and 
is recognized worldwide as a real public health problem, 
as evidenced by previous studies.28,37 Choosing the best 
prosthesis for each patient and, simultaneously, reducing 
hospital costs would be valuable both for the hospital and 
patients as it would eliminate waste, simplify processes 
and, consequently, improve the quality of healthcare and 
patient satisfaction. 
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